The goal of this activity is to provide an evidence-based rationale supporting the use of neuromodulation early in the course of the treatment of drug-resistant epilepsy (DRE) and offer guidance on patient selection for this therapy.
Upon completion of this activity, participants will have increased knowledge regarding the:
- Identification of patients with drug-resistant epilepsy (DRE) who are candidates for neuromodulation
- Available efficacy and safety data on the use of neuromodulation in patients with epilepsy
CME Released: 3/28/2018
Valid for credit through 3/28/2019
For more information and to register: click here